Stefan Gaubatz

Wuerzburg, BY 97074, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration.

Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration.

Journal: EMBO reports

Published: February 11, 2025

Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.

Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.

Journal: Oncogene

Published: July 28, 2023

Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus.

Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus.

Journal: Cell cycle (Georgetown, Tex.)

Published: September 22, 2022

Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration.

Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration.

Journal: Nucleic acids research

Published: September 06, 2022

IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability.

IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability.

Journal: Molecular cancer research : MCR

Published: July 20, 2020

Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.

Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.

Journal: PLoS genetics

Published: January 08, 2020

One way to rule them all: G2/M gene regulation by oncogenic YAP1 and B-MYB.

One way to rule them all: G2/M gene regulation by oncogenic YAP1 and B-MYB.

Journal: Molecular & cellular oncology

Published: July 15, 2019

The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.

The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.

Journal: Cell reports

Published: December 18, 2018

GAS2L3: Coordinator of cardiomyocyte cytokinesis?

GAS2L3: Coordinator of cardiomyocyte cytokinesis?

Journal: Cell cycle (Georgetown, Tex.)

Published: September 23, 2017

The microtubule-associated protein PRC1 is a potential therapeutic target for lung cancer.

The microtubule-associated protein PRC1 is a potential therapeutic target for lung cancer.

Journal: Oncotarget

Published: August 05, 2017

Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during development.

Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during development.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 13, 2017

Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.

Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.

Journal: Oncotarget

Published: October 04, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026